Left Menu
Development News Edition

Indian scientists working on ' low-cost technique uses cell shape to diagnose diseases'


Indian scientists working on ' low-cost technique uses cell shape to diagnose diseases'
Representative image

Scientists at the Indian Institute of Science (IISc) in Bengaluru are working on a novel method to diagnose a broad range of diseases, which uses the mechanical properties of cells as compared to commonly used chemical-based lab tests. G K Ananthasuresh from IISc-Bangalore, and his former student Sreenath Balakrishnan, who now works at the Indian Institute of Technology (IIT) Goa, developed a method to predict a cell's biochemistry just based on the shape of its nucleus, which hosts the genetic material.

Their mechanical model, described in the Biophysical Journal, revealed the relationship among three parameters of the nucleus such as its surface area, volume, and projected area or the two-dimensional view of a cell. According to this model, the shape of the nucleus changes as its enveloping membrane undergoes an increase in tension due to changes in a protein called actin.

Using this model, they assessed alterations in the shape of the liver cell nucleus caused by the hepatitis C virus (HCV) infection. "We have decomposed the individual contributions to nuclear morphology, and used that to predict changes in levels of proteins by merely measuring the alterations in the shape of the nucleus," Balakrishnan told PTI.

The scientists validated their findings by showing that liver cells expressing HCV proteins possessed enhanced cellular stiffness and reduced stiffness of the nucleus. They believe that measuring and standardizing changes in the mechanical properties of cells can lead to a new approach for disease diagnosis.

"Our lab's key contribution to this field is the identification that we need to employ inverse mechanics to gather more information from mechanical measurements," Balakrishnan said. "For example, cell stiffness can change due to many factors such as the nucleus, cytoskeleton, and cell membrane. By just measuring the changes in cell stiffness can we specifically say which component has changed," he said.

Conventionally, Balakrishnan said, diagnostic procedures detect the change in the levels of chemicals in tissues and cells that correspond to disease states. "We are working on what can be done with the mechanical response," Ananthasuresh told PTI on the sidelines of an international conference held last month at IIT-Mandi, where he was a keynote speaker.

"Because whenever there's a healthy cell that becomes abnormal in a disease condition, definitely its mechanical response changes because some constitution inside the cell has changed," he said. Such lab tests and chemicals assays, Balakrishnan added, involve the use of costly perishable reagents, which he believes takes the technology away from poor communities.

Additionally, the chemical tests also require sufficient quantities of sample cells, depending on the sensitivity of the tests developed. Balakrishnan said using mechanical properties instead to develop diagnostic procedures can overcome this problem since these can be measured using the same instrument repetitively for vast quantities of sample.

"For example, if you squeeze a cell, and leave it, allowing it to recover, the time of recovery can be an indicator of the health of the cell," explained Ananthasuresh, as an example of how physical forces and mechanical properties of cells can become diagnostic principles. To build diagnostic devices that work on these principles, the scientists said the physical properties of cells need to be broken down to contributions from their individual components.

They said this can be done by mechanical modeling of cells and their components, and finding how these are related to each other by physical forces. Both Ananthasuresh and Balakrishnan, however, agreed that the field is very nascent, with very few people across the world working on it.

While mechanodiagnostics may not become a clinically viable method to test for all diseases, Balakrishnan said, some conditions affecting the morphology of whole cells like cancer, malaria, and sickle cell anemia may be assessed with the emerging technologies. He said these diseases are known to cause changes in the physical and biomechanical properties of cells, which result in several-fold increases or decreases in cell stiffness and eventually cause the breakdown of the bodily functions.

Balakrishnan cited the example of a study by T. R. Kiessling from Leipzig University in Germany who used a device to capture and stretch cells flowing through them to measure their deformability, using which his team assessed suspended breast cancer cells. Researchers have also developed mechanodiagnostic devices that harness the differences in stiffness of normal red blood cells (RBCs) from infected ones to separate the diseased cells from healthy ones, according to Ananthasuresh, a recipient of the prestigious Shanti Swarup Bhatnagar Award in 2010.

"It took a long time for biologists to believe that the mechanical response does change in abnormal cells and can be an indicator of disease conditions. And now hardly, I can say 10-15 people across the world are working on mechanodiagnostics," Ananthasuresh said. "But no one disagrees that disease conditions alter the mechanical properties of cells, and that itself is a huge step forward," he added.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Download The Devdiscourse News App for Latest News.


TRENDING

OPINION/BLOG/INTERVIEW

Future of Food: Technology fostering the road to global food security

Technological innovation can help address most of the pressing issues facing the world today including food security by enhancing productivity, improving financial services, managing resources, addressing environmental concerns, etc....

Conspiracy theories on COVID 19: Legislators, Scientists, and Journalists all joined the Caravan

Conspiracy theories are not new for virus epidemics. There have been conspiracy theories on HIV-AIDS, Polio Vaccines, Ebola Virus, and several other diseases as well. However, what makes the 2019 Novel Coronavirus different from others is ...

Now it’s a war, Uganda deploys army to combat locust swarms

Its for the first time after 1986, the locust swarms have attacked Uganda twice in a season. With the increasing number of countries of Africa under attack by locust swarms, the problem seems to have taken a regional paradigm. Its very diff...

Top 10 Fake News, Myths and Realities on 2019 Novel Coronavirus COVID 19

With nearly 1500 deaths by January 14 and around 65,000 infections in China, the Novel Coronavirus 2019 has become one of the worst health epidemics of the 21st Century. However, 8,573 people have been cured but the rumor mongers are a...

Videos

Latest News

UPDATE 5-Second person dies of coronavirus in France

A second person suffering from the coronavirus died in France as health officials tried to find out how the college teacher, who had not visited any country with a known outbreak, had caught the new disease.The 60-year-old man was already s...

UPDATE 2-Lebanon reports second case of coronavirus

Lebanon confirmed its second case of coronavirus on Wednesday and said the patient was quarantined in a Beirut hospital after returning from a religious trip to Iran.The woman showed symptoms on Monday after arriving last week on the same f...

INTERVIEW-Soccer-Abbott's early vision for MLS helped silence skeptics

Mark Abbott may not be able to recall exactly what he envisioned for Major League Soccer when he became the organizations first employee in 1993 but he feels certain the league has exceeded his expectations.Abbott was the architect of MLSs ...

US STOCKS SNAPSHOT-Wall St erases gains on fears of coronavirus spreading in U.S.

U.S. stocks turned lower in afternoon trading on Wednesday in a fresh wave of selling sparked by fears of the coronavirus spreading in the United States.At 147 p.m. ET, the Dow Jones Industrial Average was down 116.19 points, or 0.43, at 26...

Give Feedback